Biosensors Intl Grp (BSNRF) 0.7500 $BSNRF
Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
PR Newswire - Wed Aug 06, 7:14AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2014 ("Q1 FY15"
.
Russia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhvvp7/russia) has announced the addition of the "Russia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Russia Interventional Cardiology Market Outlook to 2020", provides key market data on the Russia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Russia 4 Overview of Key Companies in Russia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/rhvvp7/russia
Mexico Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8plzfx/mexico) has announced the addition of the "Mexico Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Mexico Interventional Cardiology Market Outlook to 2020", provides key market data on the Mexico Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Mexico 4 Overview of Key Companies in Mexico, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Terumo Corporation - Asahi Intecc Co., Ltd. - Volcano Corporation - Cordis Corporation - Merit Medical Systems, Inc. - Biosensors International Group, Ltd. - St. Jude Medical, Inc. For more information visit http://www.researchandmarkets.com/research/8plzfx/mexico
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2014
PR Newswire - Wed Feb 12, 7:01AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2014 ("Q3 FY14" and nine months ended 31 December 2013 ("FY14 nine-month period" .
Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional
PR Newswire - Fri Feb 07, 4:41PM CST
/Continental Who's Who/ -- Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as Gynecologist with Melbourne Internal Medicine Associates.
Associated Announces Dividends
PR Newswire - Tue Jan 28, 3:05PM CST
The Board of Directors of Associated Banc-Corp (NASDAQ:ASBC) today declared a regular quarterly cash dividend of $0.09 per common share, payable on March 17, 2014, to shareholders of record at the close of business on March 3, 2014.
Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Thu Jul 18, 6:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6ctt3d/norway) has announced the addition of the "Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. "Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018", provides key market data on the market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within ten market categories - cardiac rhythm management, interventional cardiology, peripheral vascular devices, prosthetic heart valves, electrophysiology, cardiovascular surgery, external defibrillators, cardiac assist devices, cardiovascular monitoring and diagnostic devices and cardiovascular prosthetic devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key Topics Covered: 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 What is This Report About? 3 Cardiovascular Devices In Norway 3.1 Overall Revenue 3.2 Company Share 4 Cardiac Assist Devices In Norway 4.1 Overall Revenue 4.2 Overall Volume 4.3 Average Price 4.4 Distribution Share 4.5 Company Share 5 Cardiac Rhythm Management In Norway 5.1 Overall Revenue 5.2 Overall Volume 5.3 Average Price 5.4 Distribution Share 5.5 Company Share 6 Cardiovascular Monitoring and Diagnostic Devices In Norway 6.1 Overall Revenue 6.2 Overall Volume 6.3 Average Price 6.4 Distribution Share 6.5 Norway, Company Share 7 Cardiovascular Prosthetic Devices In Norway 7.1 Overall Revenue 7.2 Overall Volume 7.3 Average Price 7.4 Distribution Share 7.5 Company Share 8 Cardiovascular Surgery In Norway 8.1 Overall Revenue 8.2 Overall Volume 8.3 Average Price 8.4 Distribution Share 8.5 Company Share 9 Electrophysiology In Norway 9.1 Overall Revenue 9.2 Overall Volume 9.4 Distribution Share 9.5 Company Share 10 External Defibrillators In Norway 10.1 Overall Revenue 10.2 Overall Volume 10.3 Average Price 10.4 Distribution Share 10.5 Company Share 11 Interventional Cardiology In Norway 11.1 Overall Revenue 11.2 Overall Volume 11.3 Average Price 11.4 Distribution Share 11.5 Company Share 12 Peripheral Vascular Devices In Norway 12.1 Overall Revenue 12.2 Overall Volume 12.3 Average Price 12.4 Distribution Share 12.5 Company Share 13 Prosthetic Heart Valves In Norway 13.1 Overall Revenue 13.2 Overall Volume 13.3 Average Price 13.4 Distribution Share 13.5 Company Share 14 Overview of Key Companies in Norway Cardiovascular Devices Market 15 Appendix Companies Mentioned - AGA Medical Holdings, Inc - Abbott Laboratories - B. Braun Melsungen AG - Berlin Heart GmbH - Biosense Webster, Inc. - Biosensors International Group - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cardiac Science Corporation - CareFusion Corporation - Cordis Corporation - Covidien plc - Edwards Lifesciences Corporation - Fukuda Denshi Co., Ltd. - GE Healthcare - HeartWare International, Inc - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Opto Circuits India Limited - Philips - Schiller AG - Sorin S.p.A. - St. Jude Medical, Inc. - Teleflex Incorporated - Terumo Corporation - Thoratec Corporation - Volcano Corporation - W. L. Gore & Associates, Inc. - Welch Allyn Inc - Zoll Medical Corporation - ev3 Inc For more information visit http://www.researchandmarkets.com/research/6ctt3d/norway
Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies
M2 - Wed Jul 17, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lxnzj/global_medical) has announced the addition of iCD Research's new report "Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies" to their offering. Executives from the global medical device industry anticipate an increase in consolidation, with 55% of respondents projecting an increase in merger and acquisition (MandA) activities in 2013. This report analyzes how the media spend, marketing and sales strategies and practices, and business planning of the medical devices industry supplier companies are set to change in 2013-2014. Additionally, this report presents comparative analysis between four years of survey results (wherever applicable). This report provides the current size of the marketing and advertising budgets of global medical devices industry suppliers and how their spending will change, providing an insight into global marketing behaviour. In addition, the report identifies future gro
Boston Scientific Corporation Market Share Analysis Report
M2 - Mon Jun 10, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hjv25g/boston_scientific) has announced the addition of the "Boston Scientific Corporation Market Share Analysis" company profile to their offering. This report, Boston Scientific Corporation Market Share Analysis provides in-depth information on Boston Scientific Corporation's market position in the different medical equipment markets it operates in. The report provides Boston Scientific Corporation market share information in six key market categories - Remote Patient Monitoring - Neurostimulation Devices - Cardiac Rhythm Management - Electrophysiology - Interventional Cardiology - Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Global company shares (in Revenues) information for the key markets Boston Scientific Corporation operates in - Patient Monitoring, Neurology Devices and Cardiovascular Devices - Boston Scientific Corporation's company shares (in Revenues) information for all the key countries the company has presence in - Canada, China, Brazil, United States, Spain, Japan, Italy, Australia, Germany, United Kingdom, India and France. - Boston Scientific Corporation's company shares (in Revenues) information for all the key market categories the company has presence in - Remote Patient Monitoring, Neurostimulation Devices, Cardiac Rhythm Management, Electrophysiology, Interventional Cardiology and Peripheral Vascular Devices. - All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa. - Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries. - The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in. - Comprehensive coverage of the latest financial deals involving the company and its subsidiaries. Companies Mentioned - Biotronik SE & Co. KG - Medtronic, Inc. - St. Jude Medical, Inc. - Honeywell HomMed LLC - Philips Healthcare - GE Healthcare - Cardiocom, LLC - Robert Bosch Healthcare Systems, Inc. - Schiller AG - Nihon Kohden Corporation - Numera - Cyberonics, Inc. - Sorin S.p.A. - Taisho Biomed Instruments Co., Ltd. - Shree Pacetronix Ltd. - Biosense Webster, Inc. - C. R. Bard, Inc. - Japan Lifeline Co., Ltd. - Abbott Laboratories - Terumo Corporation - Cordis Corporation - Volcano Corporation - Lepu Medical Technology (Beijing) Co., Ltd. - Biosensors International Group, Ltd. - Asahi Intecc Co., Ltd. - MicroPort Scientific Corporation - Goodman Co., Ltd. - Eurocor GmbH - Vascular Concepts Limited - Sahajanand Medical Technologies Pvt. Ltd. - HEXACATH - AlviMedica Medical Technologies Inc. - Shanghai MicroPort Medical (Group) Co.,Ltd. - amg International GmbH - OptiMed Medizinische Instrumente GmbH - B. Braun Melsungen AG - Covidien plc - AngioDynamics, Inc. - Cook Medical Incorporated - W. L. Gore & Associates, Inc. - Bolton Medical, Inc. - Merit Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/hj...scientific About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Biosensors Completes Spectrum Dynamics Assets Acquisition
PR Newswire - Sun May 26, 7:02AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced the completion of its acquisition of substantially all assets of Spectrum Dynamics, a leader in advanced functional assessment technologies, including those used to evaluate patients for cardiac interventions.
Biosensors to Acquire Assets of Spectrum Dynamics
PR Newswire - Thu May 16, 6:41AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced on May 13, 2013 that it has entered into an agreement to acquire substantially all assets of Spectrum Dynamics, a leader in advanced functional assessment technologies, including those used to evaluate patients for cardiac interventions, subject to the fulfillment of certain conditions.
Biosensors Collaborates with Terumo to Promote Nobori(TM) in Japan
PR Newswire - Thu Feb 07, 9:04AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, has announced a collaboration with Terumo Corporation to promote the Nobori(TM) drug-eluting stent (DES) system at specific specialist cardiology centers in Japan.
Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
PR Newswire - Wed Aug 06, 7:14AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2014 ("Q1 FY15"
. Russia Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rhvvp7/russia) has announced the addition of the "Russia Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Russia Interventional Cardiology Market Outlook to 2020", provides key market data on the Russia Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Russia 4 Overview of Key Companies in Russia, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Cordis Corporation - Terumo Corporation - Biosensors International Group, Ltd. - St. Jude Medical, Inc. - Biotronik SE & Co. KG - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/rhvvp7/russia
Mexico Interventional Cardiology Market Outlook to 2020: Key players covered include Abbott, Boston Scientific, Medtronic and Cordis
M2 - Thu Jun 12, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8plzfx/mexico) has announced the addition of the "Mexico Interventional Cardiology Market Outlook to 2020" report to their offering. Our new report, "Mexico Interventional Cardiology Market Outlook to 2020", provides key market data on the Mexico Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Interventional Cardiology Market, Mexico 4 Overview of Key Companies in Mexico, Interventional Cardiology Market 5 Interventional Cardiology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned: - Medtronic, Inc. - Boston Scientific Corporation - Abbott Laboratories - Terumo Corporation - Asahi Intecc Co., Ltd. - Volcano Corporation - Cordis Corporation - Merit Medical Systems, Inc. - Biosensors International Group, Ltd. - St. Jude Medical, Inc. For more information visit http://www.researchandmarkets.com/research/8plzfx/mexico
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2014
PR Newswire - Wed Feb 12, 7:01AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2014 ("Q3 FY14"
and nine months ended 31 December 2013 ("FY14 nine-month period" . Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional
PR Newswire - Fri Feb 07, 4:41PM CST
/Continental Who's Who/ -- Carlos A. Salup is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as Gynecologist with Melbourne Internal Medicine Associates.
Associated Announces Dividends
PR Newswire - Tue Jan 28, 3:05PM CST
The Board of Directors of Associated Banc-Corp (NASDAQ:ASBC) today declared a regular quarterly cash dividend of $0.09 per common share, payable on March 17, 2014, to shareholders of record at the close of business on March 3, 2014.
Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Thu Jul 18, 6:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6ctt3d/norway) has announced the addition of the "Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. "Norway Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018", provides key market data on the market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within ten market categories - cardiac rhythm management, interventional cardiology, peripheral vascular devices, prosthetic heart valves, electrophysiology, cardiovascular surgery, external defibrillators, cardiac assist devices, cardiovascular monitoring and diagnostic devices and cardiovascular prosthetic devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key Topics Covered: 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 What is This Report About? 3 Cardiovascular Devices In Norway 3.1 Overall Revenue 3.2 Company Share 4 Cardiac Assist Devices In Norway 4.1 Overall Revenue 4.2 Overall Volume 4.3 Average Price 4.4 Distribution Share 4.5 Company Share 5 Cardiac Rhythm Management In Norway 5.1 Overall Revenue 5.2 Overall Volume 5.3 Average Price 5.4 Distribution Share 5.5 Company Share 6 Cardiovascular Monitoring and Diagnostic Devices In Norway 6.1 Overall Revenue 6.2 Overall Volume 6.3 Average Price 6.4 Distribution Share 6.5 Norway, Company Share 7 Cardiovascular Prosthetic Devices In Norway 7.1 Overall Revenue 7.2 Overall Volume 7.3 Average Price 7.4 Distribution Share 7.5 Company Share 8 Cardiovascular Surgery In Norway 8.1 Overall Revenue 8.2 Overall Volume 8.3 Average Price 8.4 Distribution Share 8.5 Company Share 9 Electrophysiology In Norway 9.1 Overall Revenue 9.2 Overall Volume 9.4 Distribution Share 9.5 Company Share 10 External Defibrillators In Norway 10.1 Overall Revenue 10.2 Overall Volume 10.3 Average Price 10.4 Distribution Share 10.5 Company Share 11 Interventional Cardiology In Norway 11.1 Overall Revenue 11.2 Overall Volume 11.3 Average Price 11.4 Distribution Share 11.5 Company Share 12 Peripheral Vascular Devices In Norway 12.1 Overall Revenue 12.2 Overall Volume 12.3 Average Price 12.4 Distribution Share 12.5 Company Share 13 Prosthetic Heart Valves In Norway 13.1 Overall Revenue 13.2 Overall Volume 13.3 Average Price 13.4 Distribution Share 13.5 Company Share 14 Overview of Key Companies in Norway Cardiovascular Devices Market 15 Appendix Companies Mentioned - AGA Medical Holdings, Inc - Abbott Laboratories - B. Braun Melsungen AG - Berlin Heart GmbH - Biosense Webster, Inc. - Biosensors International Group - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cardiac Science Corporation - CareFusion Corporation - Cordis Corporation - Covidien plc - Edwards Lifesciences Corporation - Fukuda Denshi Co., Ltd. - GE Healthcare - HeartWare International, Inc - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Opto Circuits India Limited - Philips - Schiller AG - Sorin S.p.A. - St. Jude Medical, Inc. - Teleflex Incorporated - Terumo Corporation - Thoratec Corporation - Volcano Corporation - W. L. Gore & Associates, Inc. - Welch Allyn Inc - Zoll Medical Corporation - ev3 Inc For more information visit http://www.researchandmarkets.com/research/6ctt3d/norway
Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies
M2 - Wed Jul 17, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3lxnzj/global_medical) has announced the addition of iCD Research's new report "Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies" to their offering. Executives from the global medical device industry anticipate an increase in consolidation, with 55% of respondents projecting an increase in merger and acquisition (MandA) activities in 2013. This report analyzes how the media spend, marketing and sales strategies and practices, and business planning of the medical devices industry supplier companies are set to change in 2013-2014. Additionally, this report presents comparative analysis between four years of survey results (wherever applicable). This report provides the current size of the marketing and advertising budgets of global medical devices industry suppliers and how their spending will change, providing an insight into global marketing behaviour. In addition, the report identifies future gro
Boston Scientific Corporation Market Share Analysis Report
M2 - Mon Jun 10, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hjv25g/boston_scientific) has announced the addition of the "Boston Scientific Corporation Market Share Analysis" company profile to their offering. This report, Boston Scientific Corporation Market Share Analysis provides in-depth information on Boston Scientific Corporation's market position in the different medical equipment markets it operates in. The report provides Boston Scientific Corporation market share information in six key market categories - Remote Patient Monitoring - Neurostimulation Devices - Cardiac Rhythm Management - Electrophysiology - Interventional Cardiology - Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Global company shares (in Revenues) information for the key markets Boston Scientific Corporation operates in - Patient Monitoring, Neurology Devices and Cardiovascular Devices - Boston Scientific Corporation's company shares (in Revenues) information for all the key countries the company has presence in - Canada, China, Brazil, United States, Spain, Japan, Italy, Australia, Germany, United Kingdom, India and France. - Boston Scientific Corporation's company shares (in Revenues) information for all the key market categories the company has presence in - Remote Patient Monitoring, Neurostimulation Devices, Cardiac Rhythm Management, Electrophysiology, Interventional Cardiology and Peripheral Vascular Devices. - All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa. - Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries. - The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in. - Comprehensive coverage of the latest financial deals involving the company and its subsidiaries. Companies Mentioned - Biotronik SE & Co. KG - Medtronic, Inc. - St. Jude Medical, Inc. - Honeywell HomMed LLC - Philips Healthcare - GE Healthcare - Cardiocom, LLC - Robert Bosch Healthcare Systems, Inc. - Schiller AG - Nihon Kohden Corporation - Numera - Cyberonics, Inc. - Sorin S.p.A. - Taisho Biomed Instruments Co., Ltd. - Shree Pacetronix Ltd. - Biosense Webster, Inc. - C. R. Bard, Inc. - Japan Lifeline Co., Ltd. - Abbott Laboratories - Terumo Corporation - Cordis Corporation - Volcano Corporation - Lepu Medical Technology (Beijing) Co., Ltd. - Biosensors International Group, Ltd. - Asahi Intecc Co., Ltd. - MicroPort Scientific Corporation - Goodman Co., Ltd. - Eurocor GmbH - Vascular Concepts Limited - Sahajanand Medical Technologies Pvt. Ltd. - HEXACATH - AlviMedica Medical Technologies Inc. - Shanghai MicroPort Medical (Group) Co.,Ltd. - amg International GmbH - OptiMed Medizinische Instrumente GmbH - B. Braun Melsungen AG - Covidien plc - AngioDynamics, Inc. - Cook Medical Incorporated - W. L. Gore & Associates, Inc. - Bolton Medical, Inc. - Merit Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/hj...scientific About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Biosensors Completes Spectrum Dynamics Assets Acquisition
PR Newswire - Sun May 26, 7:02AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced the completion of its acquisition of substantially all assets of Spectrum Dynamics, a leader in advanced functional assessment technologies, including those used to evaluate patients for cardiac interventions.
Biosensors to Acquire Assets of Spectrum Dynamics
PR Newswire - Thu May 16, 6:41AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced on May 13, 2013 that it has entered into an agreement to acquire substantially all assets of Spectrum Dynamics, a leader in advanced functional assessment technologies, including those used to evaluate patients for cardiac interventions, subject to the fulfillment of certain conditions.
Biosensors Collaborates with Terumo to Promote Nobori(TM) in Japan
PR Newswire - Thu Feb 07, 9:04AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, has announced a collaboration with Terumo Corporation to promote the Nobori(TM) drug-eluting stent (DES) system at specific specialist cardiology centers in Japan.
